Ocugen OCGN
NASDAQ OCGN
$0.91 -0.05 (-4.90%)
As of: Nov 12, 2026 · 12:39 PM EST

Ocugen (OCGN) Return on Invested Capital [ROIC] (2021 - 2022)

Updated

Ocugen's Return on Invested Capital [ROIC] came in at -108.41% for Q4 2022, down 50.93 percentage points from -57.48% a year earlier and down 26.62 percentage points from the prior quarter.

Analysis

Ocugen (OCGN) Return on Invested Capital [ROIC] (2021 - 2022) Analysis & Trends

For FY2021, Ocugen's Return on Invested Capital [ROIC] was -99.51%.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROIC (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 30.89%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 17.57%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 24.28%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 2.52%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 23.11%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 15.60%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -6.11%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 12.34%
10 Ocugen 322.34 Mn 87.56 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 -108.41%
Sep 30, 2022 -81.79%
Dec 31, 2021 -57.48%
API Access

Ocugen Return on Invested Capital [ROIC] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-invested-capital-%5Broic%5D&ticker=OCGN&period=max&api_key=YOUR_API_KEY